Afuco™ Anti-CSF2 ADCC Therapeutic Antibody (Namilumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CSF2. Atinumab is an immunomodulator. It binds to reticulon 4.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-259 |
Pricing | Inquiry |
Host | Human |
Target | CSF2 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | IP, IF, FuncS, FC, Neut, ELISA |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |